查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1918191

止鼾器和止鼾手术市场－2026-2031年预测

Anti-Snoring Devices and Snoring Surgery Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 147 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计止鼾设备和手术市场将从 2025 年的 18.73 亿美元成长到 2031 年的 30.31 亿美元，复合年增长率为 8.35%。

止鼾设备和治疗方案市场涵盖了从轻微良性打鼾到阻塞型睡眠呼吸中止症中止症（OSA）等更严重疾病的各种习惯性打鼾和睡眠呼吸障碍治疗方法。在人们对睡眠品质不佳的健康影响日益关注以及对有效且耐受性良好的治疗方法的需求推动下，该市场处于消费者健康产品、牙科睡眠医学和耳鼻喉科医学的交叉领域。

核心临床需求与治疗频谱

这个市场关注的是那些临床意义常被低估的疾病。打鼾是一种常见症状，会影响伴侣的睡眠，也可能是潜在阻塞型睡眠呼吸中止症（OSA）的征兆，而OSA与心血管和代谢风险密切相关。治疗方法分为器械治疗和手术干预，体现了基于病情严重程度、病因和患者意愿的阶梯式治疗模式。器械治疗（例如下颚前移装置（MAD）和舌固定装置（TRD））是首选的微创治疗方案。手术治疗的范围很广，从微创门诊手术到针对特定解剖结构（例如软颚、扁桃体或舌根）的更复杂的呼吸道重组手术。

主要市场成长驱动因素

市场扩张的根本驱动力是全球睡眠呼吸障碍盛行率的不断上升，而这与人口结构和生活方式的显着变化密切相关。肥胖率的上升是主要促成因素，因为过重会增加上呼吸道阻塞的风险。同时，人口老化导致风险族群范围扩大，因为随着老龄化，上呼吸道肌肉张力会下降。这些相互关联的趋势正在不断扩大目标患者群体。

公众和临床医生对未经治疗的睡眠呼吸中止症的健康影响的认识不断提高，正在改变市场格局。睡眠基金会和专业协会的教育活动已将打鼾和睡眠呼吸中止症定位为一项重要的公共卫生议题。这种认识的提高推动了诊断率的上升，并由此带来了对治疗方案的需求，因为越来越多的人寻求评估和治疗，以获得已证实的健康益处，而不仅仅是将其视为一种社交困扰。

技术和流程的进步一直是医疗器材和外科治疗领域发展的关键推动因素。在医疗器材领域，创新重点在于透过数位整合（包括用于使用情况追踪和疗效回馈的应用程式）来提高患者的舒适度、个人化治疗和治疗的连续性。在外科治疗领域，微创和组织保留技术正在兴起。这些技术包括使用射频消融术的门诊手术、植入（例如腭神经和舌下神经刺激设备）以及先进的雷射和机器人技术，与传统手术相比，这些技术可以缩短恢復时间并减轻疼痛，使患者更容易接受治疗方法。

对个人化和便利治疗方案日益增长的需求也在塑造着市场格局。由于无法耐受持续阳压呼吸器（CPAP），患者越来越多地寻求替代疗法。这推动了对由睡眠牙科专家提供的定制口腔矫正器以及隐蔽式植入神经刺激设备的需求，后者为中重度睡眠呼吸中止症（OSA）患者提供了一种「佩戴即忘」的解决方案。

市场限制和采用障碍

市场面临许多挑战，包括疗效不一和难以获得专业护理。由于打鼾和阻塞性睡眠呼吸中止症的解剖学原因多种多样，没有一种设备或疗法能够普遍有效，这可能导致治疗方案的反覆试验和患者满意度下降。

睡眠呼吸中止症未确诊率高是限制因素之一。许多患有症状明显且具有临床意义的阻塞性睡眠呼吸中止症（OSA）的患者并未意识到自身病情，只是将其视为打鼾或疲劳，这限制了可治疗的人。此外，手术介入必须解决患者对创伤性、潜在併发症和恢復期的担忧，即使临床上确实有必要，这些因素也会阻碍患者接受手术。

区域情势和趋势

北美是一个占据主导地位且成熟的市场。这项优势源自于该地区肥胖症和睡眠障碍的高发生率、支持睡眠诊断和专科护理的先进医疗基础设施、较高的患者意识，以及针对诊断性睡眠测试和已通过核准的治疗器械（例如，口腔矫正器、舌下神经刺激设备）的完善报销机制。该地区也是创新中心，汇聚了许多领先的医疗设备和医疗技术公司。

竞争格局与策略重点

竞争格局多元化，涵盖了专注于睡眠治疗的医疗设备製造商、客製化口腔矫正器的牙体技术所网路以及外科技术公司。医疗器材製造商的策略核心在于透过舒适度、疗效数据和数位化健康功能来实现产品差异化。主要企业正加大对临床研究的投资，以扩大其产品的保险覆盖范围，并透过直接面向消费者的行销来提高品牌知名度。

在外科领域，各公司致力于研发和销售微创系统，为外科医生提供专业培训，并收集长期疗效数据，以确保该技术符合临床指南。设备製造商与睡眠诊所/牙科诊所之间的合作十分普遍，旨在建立整合式医疗服务路径。

未来市场趋势

该市场的未来发展方向是更加个人化、与数位医疗整合以及微创解决方案的精细化。家庭睡眠测试和呼吸事件分析人工智慧技术的进步将简化诊断流程。治疗将越来越多地利用影像学和睡眠研究中的解剖学和生理学数据，以便更好地为每位患者选择最佳的设备和手术治疗方案。

将治疗设备与穿戴式睡眠追踪器结合，实现治疗的封闭回路型协调，有望成为新的成长领域。市场参与企业的成功取决于其能否证明，与标准疗法相比，其产品在长期疗效、治疗依从性和生活品质改善方面具有优势，同时还要应对复杂的医保报销环境。随着睡眠健康被持续认可为整体健康的基础，医疗需求与生活品质需求的融合将推动止鼾和睡眠呼吸中止症治疗市场的持续成长。

本报告的主要优势：

  • 深入分析：提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略进入市场的机会。
  • 市场驱动因素与未来趋势：探讨影响市场的动态因素和关键趋势及其对未来市场发展的影响。
  • 可操作的建议：利用这些见解，在动态环境中製定策略决策，发展新的业务流和收入来源。
  • 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

以下是一些公司如何使用这份报告的范例

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

  • 2021年至2025年的历史数据和2026年至2031年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区（包括国家）分類的收入和预测评估
  • 公司概况（策略、产品、财务资讯、关键发展等）

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

5. 按设备类型分類的止鼾设备和止鼾手术市场

  • 介绍
  • 口内矫正器
  • 鼻腔装置
  • 颚骨装置
  • 舌头稳定器
  • 其他的

6. 依手术方式分類的止鼾器和止鼾手术市场

  • 介绍
  • 射频消融术
  • 柱状手术
  • 注射治疗打鼾
  • 腭部增高术
  • 其他的

7. 按最终用户分類的止鼾设备和止鼾手术市场

  • 介绍
  • 医院
  • 诊所
  • 其他的

8. 各地区止鼾器及止鼾手术市场

  • 介绍
  • 北美洲
    • 依设备类型
    • 透过外科手术
    • 最终用户
    • 按国家/地区
      • 我们
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依设备类型
    • 透过外科手术
    • 最终用户
    • 按国家/地区
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 依设备类型
    • 透过外科手术
    • 最终用户
    • 按国家/地区
      • 英国
      • 德国
      • 法国
      • 西班牙
      • 其他的
  • 中东和非洲
    • 依设备类型
    • 透过外科手术
    • 最终用户
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 依设备类型
    • 透过外科手术
    • 最终用户
    • 按国家/地区
      • 中国
      • 日本
      • 印度
      • 韩国
      • 台湾
      • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章：公司简介

  • Somnowell Ltd.
  • Inspire Medical Systems, Inc.
  • Zelegent, Inc.
  • GoodSomnia AB
  • Signifier Medical Technologies
  • ResMed Inc.
  • Fisher & Paykel Healthcare Ltd.
  • Apnea Sciences Corporation
  • Philips Respironics

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061616019

Anti-Snoring Devices And Snoring Surgery Market is anticipated to grow at a 8.35% CAGR, growing from USD 1.873 billion in 2025 to USD 3.031 billion in 2031.

The anti-snoring devices and surgery market addresses a spectrum of treatments for habitual snoring and sleep-disordered breathing, ranging from mild, benign snoring to more serious conditions like obstructive sleep apnea (OSA). This market sits at the intersection of consumer health, dental sleep medicine, and otolaryngology, driven by increasing recognition of the health implications of poor sleep and the demand for effective, tolerable interventions.

Core Clinical Need and Treatment Spectrum

The market caters to a condition often underestimated in its clinical significance. Snoring, while common, can be a primary complaint disrupting bed-partner sleep or an indicator of underlying OSA, which carries cardiovascular and metabolic risks. The treatment landscape is bifurcated into device-based therapies and surgical interventions, reflecting a stepped-care approach based on severity, etiology, and patient preference. Device-based solutions, including Mandibular Advancement Devices (MADs) and Tongue Retaining Devices (TRDs), represent a first-line, minimally invasive option. Surgical procedures range from minimally invasive office-based techniques to more complex airway reconstructions, targeting specific anatomical contributors like the soft palate, tonsils, or tongue base.

Primary Market Growth Drivers

Market expansion is fundamentally fueled by the rising global prevalence of sleep-disordered breathing, closely linked to powerful demographic and lifestyle trends. The increasing prevalence of obesity is a paramount driver, as excess weight contributes to upper airway collapsibility. Concurrently, an aging population presents a growing at-risk cohort, as muscle tone in the upper airway diminishes with age. These intertwined trends ensure a continuously expanding addressable patient population.

Heightened public and clinical awareness of the health consequences of untreated sleep apnea is transforming the market. Educational campaigns by sleep foundations and professional societies have moved snoring and sleep apnea higher on the public health agenda. This increased awareness prompts more individuals to seek evaluation and treatment, not merely for social nuisance but for documented health benefits, thereby driving diagnosis rates and subsequent demand for therapeutic solutions.

Technological and procedural advancements are critical catalysts across both device and surgical segments. In the device sector, innovation focuses on improving patient comfort, customizability, and adherence through digital integration, such as apps for usage tracking and efficacy feedback. For surgical treatments, the trend is toward minimally invasive, tissue-sparing techniques. These include office-based procedures using radiofrequency ablation, implants (e.g., palatal and hypoglossal nerve stimulation), and refined laser or robotic techniques that offer reduced recovery time and pain compared to traditional surgery, making intervention more acceptable to patients.

The growing preference for personalized and convenient care also shapes the market. Patients increasingly seek alternatives to Continuous Positive Airway Pressure (CPAP), often citing intolerance to the therapy. This drives demand for custom-fitted oral appliances provided by dental sleep specialists and for discreet, implantable neurostimulation devices that offer a "wear-and-forget" solution for moderate-to-severe OSA.

Market Restraints and Adoption Barriers

The market faces significant challenges related to efficacy variability and access to specialized care. The heterogeneous anatomical causes of snoring and OSA mean no single device or procedure is universally effective, leading to potential trial-and-error in treatment selection and possible patient dissatisfaction.

A major restraint is the substantial rate of undiagnosed sleep apnea. Many individuals with symptomatic, clinically significant OSA remain unaware of their condition, perceiving it merely as snoring or fatigue, which limits the treated population. Furthermore, surgical interventions contend with patient apprehension regarding invasiveness, potential complications, and recovery downtime, which can deter adoption even when clinically indicated.

Geographic Landscape and Regional Dynamics

North America represents a dominant and sophisticated market. This leadership is attributed to a high prevalence of obesity and sleep disorders, advanced healthcare infrastructure supporting sleep diagnostics and specialty care, high patient awareness, and robust reimbursement pathways for both diagnostic sleep studies and approved therapeutic devices (e.g., oral appliances, hypoglossal nerve stimulation). The region is also a hub for innovation, hosting many leading device manufacturers and medical technology companies.

Competitive Landscape and Strategic Focus

The competitive environment is diverse, encompassing medical device companies specializing in sleep therapy, dental laboratory networks for custom oral appliances, and surgical technology firms. For device manufacturers, strategy revolves around product differentiation through comfort, efficacy data, and digital health features. Key players invest in clinical studies to expand insurance coverage for their products and in direct-to-consumer marketing to raise awareness.

In the surgical domain, companies focus on developing and marketing minimally invasive systems, providing specialized training to surgeons, and generating long-term outcome data to establish their techniques within clinical guidelines. Partnerships between device companies and sleep clinics/dental practices are common to create integrated care pathways.

Future Market Trajectory

The future trajectory of this market is oriented toward greater personalization, integration of digital health, and refinement of minimally invasive solutions. Advances in home sleep testing and artificial intelligence for respiratory event analysis will streamline diagnosis. Treatment will increasingly leverage anatomical and physiological data (from imaging and sleep studies) to better match patients with the most appropriate device or surgical target.

The convergence of wearable sleep trackers with therapeutic devices, enabling closed-loop adjustment of therapy, represents a growing frontier. Success for market participants will depend on demonstrating superior long-term outcomes, adherence, and quality-of-life improvements compared to standard therapies, while navigating complex reimbursement landscapes. As sleep health continues to gain recognition as a pillar of overall wellness, the market for anti-snoring and sleep apnea interventions is poised for sustained growth, driven by the convergence of medical necessity and quality-of-life demand.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Anti-Snoring Devices and Snoring Surgery Market Segmentation

  • By Device Type
  • Oral Appliances
  • Nasal Devices
  • Chin Devices
  • Tongue-Stabilizing Devices
  • Others
  • By Surgical Procedure
  • Radiofrequency Ablation
  • Pillar Procedure
  • Injection Snoreplasty
  • Palatal Stiffening
  • Others
  • By End-User
  • Hospitals
  • Clinics
  • Others
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET BY DEVICE TYPE

  • 5.1. Introduction
  • 5.2. Oral Appliances
  • 5.3. Nasal devices
  • 5.4. Chin Devices
  • 5.5. Tongue-Stabilizing Devices
  • 5.6. Others

6. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET BY SURGICAL PROCEDURE

  • 6.1. Introduction
  • 6.2. Radiofrequency Ablation
  • 6.3. Pillar Procedure
  • 6.4. Injection Snoreplasty
  • 6.5. Palatal Stiffening
  • 6.6. Others

7. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Clinics
  • 7.4. Others

8. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Device Type
    • 8.2.2. By Surgical Procedure
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Device Type
    • 8.3.2. By Surgical Procedure
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Device Type
    • 8.4.2. By Surgical Procedure
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Device Type
    • 8.5.2. By Surgical Procedure
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Device Type
    • 8.6.2. By Surgical Procedure
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Somnowell Ltd.
  • 10.2. Inspire Medical Systems, Inc.
  • 10.3. Zelegent, Inc.
  • 10.4. GoodSomnia AB
  • 10.5. Signifier Medical Technologies
  • 10.6. ResMed Inc.
  • 10.7. Fisher & Paykel Healthcare Ltd.
  • 10.8. Apnea Sciences Corporation
  • 10.9. Philips Respironics

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations